Insider Transactions in Q3 2023 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2023
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
5,000
-2.4%
|
$575,000
$115.02 P/Share
|
|
Sep 12
2023
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.34%
|
$60,000
$12.98 P/Share
|
|
Sep 01
2023
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
5,000
-2.4%
|
$550,000
$110.06 P/Share
|
|
Sep 01
2023
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.34%
|
$60,000
$12.98 P/Share
|
|
Sep 01
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
824
-4.56%
|
$90,640
$110.93 P/Share
|
|
Aug 30
2023
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
2,733
-25.13%
|
$292,431
$107.56 P/Share
|
|
Aug 30
2023
|
Darin Lippoldt Chief Legal Officer |
SELL
Bona fide gift
|
Direct |
190
-0.4%
|
-
|
|
Aug 28
2023
|
Ingrid Delaet Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
1,431
-19.44%
|
$153,117
$107.52 P/Share
|
|
Aug 21
2023
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,198
-9.77%
|
$342,186
$107.38 P/Share
|
|
Aug 21
2023
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,132
-4.34%
|
$228,124
$107.39 P/Share
|
|
Aug 21
2023
|
Jude Onyia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,198
-24.91%
|
$342,186
$107.37 P/Share
|
|
Aug 21
2023
|
Ingrid Delaet Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
1,404
-23.21%
|
$150,228
$107.42 P/Share
|
|
Aug 21
2023
|
Kyle Gano Chief Business Development Off |
SELL
Open market or private sale
|
Direct |
2,132
-1.61%
|
$228,124
$107.41 P/Share
|
|
Aug 21
2023
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,328
-1.83%
|
$998,096
$107.4 P/Share
|
|
Aug 21
2023
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
1,600
-20.53%
|
$171,200
$107.41 P/Share
|
|
Aug 21
2023
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,132
-10.54%
|
$228,124
$107.41 P/Share
|
|
Aug 21
2023
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,132
-7.29%
|
$228,124
$107.39 P/Share
|
|
Aug 21
2023
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,600
-4.21%
|
$171,200
$107.4 P/Share
|